VJOncology has assembled a panel of leading experts, who offer their perspectives on the latest developments in lung cancer presented at the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021.

In this podcast, Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust London, UK, is joined by Samreen Ahmed, MBBS, MSc(onc), FRCP, MD, University Hospitals of Leicester Trust, Leicester, UK, David Gilligan, MBChB, FRCPE, FRCR, Addenbrooke’s & Papworth Hospitals, Cambridge, UK and Neal Navani, MBBS, PhD, University College London Hospitals NHS Foundation Trust, London, UK.

Tune in to hear the expert panel discuss the key learnings from the 19th BTOG Annual Conference, as they offer their perspectives on the impact of the COVID-19 pandemic on lung cancer care and managing patients with malignant pleural effusions. The panel also discusses the latest developments in novel KRAS inhibitors and antibody-drug conjugates (ADCs), radiotherapy in the adjuvant setting and the role of neoadjuvant checkpoint inhibitor therapies.